PE-backed Arcadia Consumer Healthcare buys Kaopectate

Arcadia Consumer Healthcare Inc, which is backed by Avista Capital Partners, has acquired anti-diarrheal medicine Kaopectate from Sanofi.

20 March 2020•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles